Literature DB >> 21894248

Sudden cardiac arrest in apical hypertrophic cardiomyopathy.

Imdad Ahmed1, Stephen J Smalley, Dennis W X Zhu, Ranjan Dahiya, Chad M House, William B Nelson.   

Abstract

We present two cases of cardiac arrest, presumably attributable to apical hypertrophic cardiomyopathy(HCM). The first case was a 37-year-old Asian man known to have an apical HCM and was successfully resuscitated from an "out of hospital" ventricular fibrillation arrest. He underwent an electrophysiological study that was unable to induce tachyarrhythmias, which may not be surprising. He did receive an automated internal cardioverter defibrillator (AICD) in compliance with his class I indication for an implantable defibrillator. The second patient was an 86-year-old Caucasian woman with a cardiac history significant for apical HCM, coronary artery disease, diastolic heart failure, and monomorphic ventricular tachycardia. She underwent electrophysiological testing for frequent dizziness and monomorphic ventricular tachycardia of a right ventricular origin was induced. She received an AICD for sudden cardiac death prevention. Though lethal ventricular arrhythmias have been reported in patients with apical HCM, the prevailing consensus is that the prognosis of apical HCM is benign. Whether these accounts are truly exceptional occurrences for this rare and conventionally regarded benign condition or whether they represent an under-appreciated risk for sudden cardiac arrest is an intriguing question.

Entities:  

Year:  2009        PMID: 21894248      PMCID: PMC3027893          DOI: 10.1136/bcr.04.2009.1753

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  16 in total

1.  Long-term outcome in patients with apical hypertrophic cardiomyopathy.

Authors:  Maria J Eriksson; Brian Sonnenberg; Anna Woo; Paul Rakowski; Thomas G Parker; E Douglas Wigle; Harry Rakowski
Journal:  J Am Coll Cardiol       Date:  2002-02-20       Impact factor: 24.094

Review 2.  Primary prevention of sudden death as a novel treatment strategy in hypertrophic cardiomyopathy.

Authors:  Barry J Maron; N A Mark Estes; Martin S Maron; Adrian K Almquist; Mark S Link; James E Udelson
Journal:  Circulation       Date:  2003-06-17       Impact factor: 29.690

3.  Contemporary considerations for risk stratification, sudden death and prevention in hypertrophic cardiomyopathy.

Authors:  B J Maron
Journal:  Heart       Date:  2003-09       Impact factor: 5.994

4.  Cardiac arrest and ventricular tachycardia in Japanese-type apical hypertrophic cardiomyopathy.

Authors:  Denio Ridjab; Matthias Koch; Markus Zabel; Heinz-Peter Schultheiss; Andreas J Morguet
Journal:  Cardiology       Date:  2006-06-27       Impact factor: 1.869

5.  Serious arrhythmias in patients with apical hypertrophic cardiomyopathy.

Authors:  K Okishige; T Sasano; K Yano; K Azegami; K Suzuki; K Itoh
Journal:  Intern Med       Date:  2001-05       Impact factor: 1.271

6.  Hypertrophic cardiomyopathy in Tuscany: clinical course and outcome in an unselected regional population.

Authors:  F Cecchi; I Olivotto; A Montereggi; G Santoro; A Dolara; B J Maron
Journal:  J Am Coll Cardiol       Date:  1995-11-15       Impact factor: 24.094

7.  Comparison of prevalence of apical hypertrophic cardiomyopathy in Japan and the United States.

Authors:  Hiroaki Kitaoka; Yoshinori Doi; Susan A Casey; Nobuhiko Hitomi; Takashi Furuno; Barry J Maron
Journal:  Am J Cardiol       Date:  2003-11-15       Impact factor: 2.778

8.  Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy.

Authors:  Barry J Maron; Paolo Spirito; Win-Kuang Shen; Tammy S Haas; Francesco Formisano; Mark S Link; Andrew E Epstein; Adrian K Almquist; James P Daubert; Thorsten Lawrenz; Giuseppe Boriani; N A Mark Estes; Stefano Favale; Marco Piccininno; Stephen L Winters; Massimo Santini; Sandro Betocchi; Fernando Arribas; Mark V Sherrid; Gianfranco Buja; Christopher Semsarian; Paolo Bruzzi
Journal:  JAMA       Date:  2007-07-25       Impact factor: 56.272

9.  Giant T wave inversion as a manifestation of asymmetrical apical hypertrophy (AAH) of the left ventricle. Echocardiographic and ultrasono-cardiotomographic study.

Authors:  T Sakamoto; C Tei; M Murayama; H Ichiyasu; Y Hada
Journal:  Jpn Heart J       Date:  1976-09

Review 10.  The management of hypertrophic cardiomyopathy.

Authors:  P Spirito; C E Seidman; W J McKenna; B J Maron
Journal:  N Engl J Med       Date:  1997-03-13       Impact factor: 91.245

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.